nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Norepinephrine—SLC18A2—schizophrenia	0.00953	0.166	CrCbGaD
Salbutamol—Phenylephrine—MAOA—schizophrenia	0.00896	0.156	CrCbGaD
Salbutamol—Clenbuterol—TNF—schizophrenia	0.00794	0.138	CrCbGaD
Salbutamol—Clenbuterol—CYP1A2—schizophrenia	0.00582	0.101	CrCbGaD
Salbutamol—Phenylephrine—CYP1A2—schizophrenia	0.00526	0.0915	CrCbGaD
Salbutamol—Carteolol—CYP2D6—schizophrenia	0.00522	0.0909	CrCbGaD
Salbutamol—Epinephrine—TNF—schizophrenia	0.00333	0.058	CrCbGaD
Salbutamol—Nadolol—ABCB1—schizophrenia	0.00332	0.0578	CrCbGaD
Salbutamol—Norepinephrine—DRD2—schizophrenia	0.00294	0.0512	CrCbGaD
Salbutamol—Norepinephrine—CYP1A2—schizophrenia	0.00269	0.0469	CrCbGaD
Salbutamol—Epinephrine—CYP1A2—schizophrenia	0.00244	0.0425	CrCbGaD
Salbutamol—ADRB2—GPCR downstream signaling—CHRM1—schizophrenia	0.000807	0.000856	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL3RA—schizophrenia	0.000804	0.000853	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL3RA—schizophrenia	0.000786	0.000834	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000779	0.000827	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—GRM5—schizophrenia	0.000767	0.000814	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000762	0.000809	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DGKI—schizophrenia	0.000751	0.000797	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GRM5—schizophrenia	0.00075	0.000796	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CHRM1—schizophrenia	0.000749	0.000795	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DGKI—schizophrenia	0.000735	0.000779	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CHRM1—schizophrenia	0.000733	0.000778	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL3RA—schizophrenia	0.00073	0.000775	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL3RA—schizophrenia	0.000714	0.000758	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCK—schizophrenia	0.000701	0.000744	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GRM5—schizophrenia	0.000696	0.000739	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP1R1B—schizophrenia	0.000687	0.000729	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCK—schizophrenia	0.000686	0.000728	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PDE4B—schizophrenia	0.000684	0.000725	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GRM5—schizophrenia	0.000681	0.000723	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCKAR—schizophrenia	0.000673	0.000714	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP1R1B—schizophrenia	0.000672	0.000713	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PDE4B—schizophrenia	0.000669	0.000709	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCKAR—schizophrenia	0.000658	0.000698	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000657	0.000697	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000652	0.000692	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000648	0.000687	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FZD3—schizophrenia	0.000638	0.000677	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—ADORA2A—schizophrenia	0.000638	0.000677	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCK—schizophrenia	0.000637	0.000676	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FZD3—schizophrenia	0.000625	0.000663	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCK—schizophrenia	0.000623	0.000661	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PDE4B—schizophrenia	0.000621	0.000659	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCKAR—schizophrenia	0.000611	0.000648	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPY—schizophrenia	0.000609	0.000646	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PDE4B—schizophrenia	0.000607	0.000644	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP3CC—schizophrenia	0.0006	0.000637	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FES—schizophrenia	0.0006	0.000637	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GRM2—schizophrenia	0.0006	0.000637	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TAAR6—schizophrenia	0.0006	0.000637	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCKAR—schizophrenia	0.000597	0.000634	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPY—schizophrenia	0.000596	0.000632	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.000594	0.00063	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—schizophrenia	0.000593	0.000629	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—ADORA2A—schizophrenia	0.000592	0.000628	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1B—schizophrenia	0.000588	0.000624	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OXT—schizophrenia	0.000588	0.000624	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GRM2—schizophrenia	0.000587	0.000623	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP3CC—schizophrenia	0.000587	0.000623	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TAAR6—schizophrenia	0.000587	0.000623	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FES—schizophrenia	0.000587	0.000623	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.000586	0.000621	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—schizophrenia	0.00058	0.000616	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—ADORA2A—schizophrenia	0.000579	0.000615	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OXT—schizophrenia	0.000575	0.00061	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1B—schizophrenia	0.000575	0.00061	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1A—schizophrenia	0.000566	0.0006	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPS—schizophrenia	0.000557	0.000591	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NGEF—schizophrenia	0.000555	0.000589	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1A—schizophrenia	0.000554	0.000587	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPY—schizophrenia	0.000553	0.000587	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD1—schizophrenia	0.000546	0.00058	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2C—schizophrenia	0.000546	0.00058	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPS—schizophrenia	0.000545	0.000578	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NGEF—schizophrenia	0.000543	0.000576	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTS—schizophrenia	0.000543	0.000576	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPY—schizophrenia	0.000541	0.000574	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD1—schizophrenia	0.000535	0.000567	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2C—schizophrenia	0.000535	0.000567	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1B—schizophrenia	0.000534	0.000566	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OXT—schizophrenia	0.000534	0.000566	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTS—schizophrenia	0.000531	0.000563	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD3—schizophrenia	0.000529	0.000562	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OXT—schizophrenia	0.000522	0.000554	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1B—schizophrenia	0.000522	0.000554	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD3—schizophrenia	0.000518	0.000549	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1A—schizophrenia	0.000514	0.000545	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD4—schizophrenia	0.000514	0.000545	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GRM3—schizophrenia	0.00051	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RGS4—schizophrenia	0.00051	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RTN4—schizophrenia	0.00051	0.000542	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPS—schizophrenia	0.000506	0.000537	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	0.000503	0.000533	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	0.000503	0.000533	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR6—schizophrenia	0.000501	0.000532	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RTN4—schizophrenia	0.000499	0.00053	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RGS4—schizophrenia	0.000499	0.00053	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GRM3—schizophrenia	0.000499	0.00053	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000498	0.000528	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD1—schizophrenia	0.000496	0.000527	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2C—schizophrenia	0.000496	0.000527	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000495	0.000525	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPS—schizophrenia	0.000495	0.000525	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000494	0.000524	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000491	0.000521	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CNR1—schizophrenia	0.000491	0.000521	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR6—schizophrenia	0.00049	0.00052	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.000488	0.000518	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	0.000485	0.000515	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	0.000485	0.000515	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAG—schizophrenia	0.000484	0.000513	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD3—schizophrenia	0.000481	0.00051	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	0.00048	0.000509	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD2—schizophrenia	0.000479	0.000508	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR7—schizophrenia	0.000479	0.000508	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAG—schizophrenia	0.000473	0.000502	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	0.00047	0.000499	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	0.000468	0.000497	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	0.000468	0.000497	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD4—schizophrenia	0.000467	0.000495	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	0.000456	0.000484	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000455	0.000483	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000449	0.000476	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CNR1—schizophrenia	0.000446	0.000473	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CHRM1—schizophrenia	0.000443	0.00047	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	0.000436	0.000462	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD2—schizophrenia	0.000435	0.000461	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR7—schizophrenia	0.000435	0.000461	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	0.000433	0.000459	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL3RA—schizophrenia	0.000431	0.000458	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRODH—schizophrenia	0.000426	0.000452	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	0.000425	0.000451	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	0.000425	0.000451	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	0.000422	0.000448	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRG3—schizophrenia	0.000421	0.000447	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TLE1—schizophrenia	0.000421	0.000447	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GFAP—schizophrenia	0.000416	0.000441	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRG3—schizophrenia	0.000412	0.000437	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TLE1—schizophrenia	0.000412	0.000437	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GRM5—schizophrenia	0.000411	0.000437	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GFAP—schizophrenia	0.000407	0.000432	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GRM5—schizophrenia	0.000402	0.000427	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TLE3—schizophrenia	0.000398	0.000423	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TLE3—schizophrenia	0.00039	0.000414	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCK—schizophrenia	0.000376	0.000399	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCK—schizophrenia	0.000368	0.000391	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4B—schizophrenia	0.000367	0.000389	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCKAR—schizophrenia	0.000361	0.000383	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	0.000359	0.000381	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	0.000353	0.000374	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	0.00035	0.000371	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MPC2—schizophrenia	0.000347	0.000368	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000344	0.000365	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	0.000342	0.000363	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000336	0.000357	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGA—schizophrenia	0.000335	0.000356	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	0.000335	0.000356	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGA—schizophrenia	0.000328	0.000348	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	0.000328	0.000348	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPY—schizophrenia	0.000327	0.000347	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	0.000327	0.000347	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	0.000327	0.000347	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCH2—schizophrenia	0.000323	0.000342	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	0.00032	0.000339	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPY—schizophrenia	0.00032	0.000339	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	0.00032	0.000339	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OXT—schizophrenia	0.000315	0.000335	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1B—schizophrenia	0.000315	0.000335	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OXT—schizophrenia	0.000308	0.000327	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	0.000308	0.000327	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	0.000304	0.000323	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1A—schizophrenia	0.000304	0.000322	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NDST3—schizophrenia	0.000303	0.000322	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPS—schizophrenia	0.000299	0.000317	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	0.000298	0.000316	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	0.000297	0.000315	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD1—schizophrenia	0.000293	0.000311	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2C—schizophrenia	0.000293	0.000311	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPS—schizophrenia	0.000292	0.00031	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000288	0.000305	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000288	0.000305	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	0.000287	0.000304	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD1—schizophrenia	0.000287	0.000304	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK2—schizophrenia	0.000285	0.000303	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD3—schizophrenia	0.000284	0.000301	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	0.000279	0.000296	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD3—schizophrenia	0.000278	0.000295	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD4—schizophrenia	0.000276	0.000292	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DAO—schizophrenia	0.000274	0.000291	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD4—schizophrenia	0.00027	0.000286	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CNR1—schizophrenia	0.000263	0.000279	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PNP—schizophrenia	0.000263	0.000279	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CNR1—schizophrenia	0.000257	0.000273	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD2—schizophrenia	0.000257	0.000272	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR7—schizophrenia	0.000257	0.000272	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR7—schizophrenia	0.000251	0.000266	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD2—schizophrenia	0.000251	0.000266	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000245	0.000259	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRL—schizophrenia	0.000242	0.000257	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRL—schizophrenia	0.000237	0.000252	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.00023	0.000244	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—S100B—schizophrenia	0.000226	0.00024	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—S100B—schizophrenia	0.000221	0.000235	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ERBB4—schizophrenia	0.000216	0.000229	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	0.000211	0.000224	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.000208	0.000221	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	0.000203	0.000216	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRG1—schizophrenia	0.000199	0.000212	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	0.000199	0.000211	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MEF2C—schizophrenia	0.000198	0.00021	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRG1—schizophrenia	0.000195	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	0.000193	0.000205	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	0.000191	0.000203	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	0.000187	0.000198	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	0.000187	0.000198	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPH1—schizophrenia	0.000185	0.000197	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCLM—schizophrenia	0.000185	0.000197	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	0.000183	0.000194	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	0.00018	0.000191	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	0.000176	0.000187	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRKD1—schizophrenia	0.000174	0.000185	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—schizophrenia	0.000167	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOA1—schizophrenia	0.000165	0.000175	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—schizophrenia	0.000164	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOA1—schizophrenia	0.000162	0.000172	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—schizophrenia	0.00016	0.000169	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—schizophrenia	0.000156	0.000166	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GAPDH—schizophrenia	0.000145	0.000154	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	0.000145	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CLOCK—schizophrenia	0.000144	0.000153	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	0.000142	0.00015	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPH2—schizophrenia	0.00014	0.000149	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNB2—schizophrenia	0.00014	0.000149	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DPYD—schizophrenia	0.000138	0.000147	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNA1C—schizophrenia	0.000128	0.000136	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3C2A—schizophrenia	0.000125	0.000133	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SNAP25—schizophrenia	0.000112	0.000119	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2D6—schizophrenia	0.000112	0.000119	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	0.000107	0.000114	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	0.000105	0.000111	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP1A2—schizophrenia	0.000102	0.000108	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TH—schizophrenia	0.0001	0.000106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	9.75e-05	0.000103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	9.53e-05	0.000101	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EP300—schizophrenia	9.53e-05	0.000101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EP300—schizophrenia	9.32e-05	9.89e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—schizophrenia	8.51e-05	9.03e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTP1—schizophrenia	8.47e-05	8.99e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOA—schizophrenia	8.45e-05	8.97e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCB1—schizophrenia	8.02e-05	8.51e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G4A—schizophrenia	7.78e-05	8.26e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—schizophrenia	7.78e-05	8.26e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—schizophrenia	6.88e-05	7.3e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TP53—schizophrenia	6.82e-05	7.23e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TP53—schizophrenia	6.67e-05	7.08e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—schizophrenia	6.4e-05	6.79e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOA1—schizophrenia	6.33e-05	6.72e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—schizophrenia	5.76e-05	6.11e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—schizophrenia	5.63e-05	5.98e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—EP300—schizophrenia	3.65e-05	3.87e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—schizophrenia	2.21e-05	2.34e-05	CbGpPWpGaD
